about
EULAR-PReS points to consider for the use of imaging in the diagnosis and management of juvenile idiopathic arthritis in clinical practiceVitamin D—update for the pediatric rheumatologistsEfficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study.Educational recommendations for the conduct, content and format of EULAR musculoskeletal ultrasound Teaching the Teachers Courses.Distribution of MEFV gene mutations and R202Q polymorphism in the Serbian population and their influence on oxidative stress and clinical manifestations of inflammation.HDAC inhibition in rheumatoid arthritis and juvenile idiopathic arthritis.Vitamin D receptor agonists' anti-inflammatory properties.Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO).The OMERACT Ultrasound Group: A Report from the OMERACT 2016 Meeting and Perspectives.Two-year Efficacy and Safety of Etanercept in Pediatric Patients with Extended Oligoarthritis, Enthesitis-related Arthritis, or Psoriatic Arthritis.Preliminary Definitions for the Sonographic Features of Synovitis in Children.Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis.Toward Standardized Musculoskeletal Ultrasound in Pediatric Rheumatology: Normal Age-Related Ultrasound Findings.Etanercept reduces matrix metalloproteinase-9 level in children with polyarticular juvenile idiopathic arthritis and TNF-alpha-308GG genotype.Outcome of Juvenile Idiopathic Arthritis Associated Uveitis in Two Disease SubtypesIncreased activity of lymph node cells in experimental thermal injury: changes in accessory cells in injured area-draining lymph nodesAdditional impact on muscle function when treating active rheumatoid arthritis patients with high alphacalcidol dosesAlfacalcidol modulates oxidative stress parameters in the peripheral blood of patients with active rheumatoid arthritisDeep nasopharyngeal aspiration as a treatment option for conversion of supraventricular paroxysmal tachycardia in infants: First experiencesSafety and efficacy of an oral histone deacetylase inhibitor in systemic-onset juvenile idiopathic arthritisBiologic therapy of rheumatoid arthritisThe association of CAT-262C/T polymorphism with catalase activity and treatment response in juvenile idiopathic arthritisEstablishing an Updated Core Domain Set for Studies in Juvenile Idiopathic Arthritis: A Report from the OMERACT 2018 JIA Workshop[Correlation between bronchoalveolar lavage and lung function in patients with systemic sclerosis and rheumatoid arthritis]
P50
Q26798354-1CF5D6A9-8F86-4D3E-97BA-F0548E11CAE6Q30375070-6D8EA16D-2450-4FC1-A54F-0C8C8FE02F22Q33659233-9F484BF6-4FDF-46DD-82D5-D13591E8F41CQ36215834-C6400152-722C-419F-B678-6D7DCB04D33BQ37057769-80C5B784-6D11-4DF0-8DAF-12CA02A7513BQ37838731-3D2F1A22-1A42-4718-BBE6-CFB715233AC0Q38206253-4C31AA31-C85C-41A1-9585-1FD21AAE67F9Q38374642-366CABE2-B272-43BD-BDEF-C795F1B4DB43Q38916596-5213BFB8-0182-4B6E-A8C3-B34D96763F4AQ40355364-AA702DC9-F5F9-4F9A-A50E-381427219F49Q40771281-C9DFD441-A3BA-49D8-9244-28537E14721AQ48772188-B4A3B8F5-5566-4D25-8DD4-4F54B23040C0Q50976726-A3E02EE8-CA48-4FF6-A480-E7A6C2275B08Q51831708-0F852059-EC24-4570-9293-F263E7636521Q54421616-180CAC8F-E121-4E99-8802-231AD7342C20Q58134161-23CF5315-705D-4091-825B-13ABB35411AFQ60359265-050669B7-23F3-4BE5-8A2A-9E61F812A40BQ61633699-988563CB-EA35-48CA-93F9-C6383D0B9F26Q61633700-3B93EEE5-3C11-4B64-990B-A0BCF8979914Q61633703-D772B5A0-9274-4D82-A991-66AE2680562BQ61633704-65D613FE-E9F1-485B-967F-036CA6FD7206Q61633705-AE716B35-E733-414F-8307-49BD9B2FAE6DQ91214513-FBABABC6-D944-4843-8DEC-9A590982E093Q91633732-2D616441-71E4-40E7-94A6-DB52D7AA7AD1Q94472551-6D99EEED-3BCF-47CC-8E80-A0F8862C3173
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
J Vojinovic
@nl
J Vojinovic
@sl
Jelena Vojinovic
@en
Jelena Vojinovic
@es
type
label
J Vojinovic
@nl
J Vojinovic
@sl
Jelena Vojinovic
@en
Jelena Vojinovic
@es
altLabel
J Vojinovic
@en
prefLabel
J Vojinovic
@nl
J Vojinovic
@sl
Jelena Vojinovic
@en
Jelena Vojinovic
@es
P106
P1153
6603423836
P21
P31
P496
0000-0002-6701-3370